IMAX (IMAX) CEO exercises options, sells 121,220 shares under 10b5-1 plan

Rhea-AI Filing Summary

IMAX CORP Chief Executive Officer Richard L. Gelfond converted stock options into 121,220 common shares at an exercise price of $31.40 per share and on the same day sold 121,220 common shares at an average price of $40.0993 per share.

The conversion and sale were carried out under a pre-arranged Rule 10b5-1 trading plan. After these transactions, he directly holds 765,002 common shares, along with remaining outstanding options over 1,697,475 shares and 231,562 restricted share units, indicating he retains a substantial equity stake.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

GELFOND RICHARD L

(Last) (First) (Middle)

902 BROADWAY

20TH FLOOR

(Street)

NEW YORK 10010-6002

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
IMAX CORP [ IMAX ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Executive Officer

3. Date of Earliest Transaction (Month/Day/Year)
03/10/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
common shares (opening balance)								765,002	D
common shares	03/10/2026		C		121,220(1)	A	$31.4	886,222	D
common shares	03/10/2026		S		121,220	D	$40.0993	765,002	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
stock options (to buy)(2)	$31.4	03/10/2026		C			121,220	03/10/2026(3)	06/07/2026	common shares	121,220	$31.4	365,064(4)	D

Explanation of Responses:

1. Represents the conversion upon exercise of stock options into common shares pursuant to a 10b5-1 Plan dated December 9, 2026.

2. These options were issued in 2016 and are set to expire on June 7, 2026.

3. The stock options became exercisable in three installments: 162,095 on each of June 7, 2016 and September 1, 2016 and 162,094 on December 31, 2016.

4. This represents the number of common shares for this transaction only. Mr. Gelfond's aggregate remaining outstanding option, restricted share unit and common share balances following these transactions will be 1,697,475, 231,562 and 765,002, respectively.

Remarks:

	/s/ Richard L. Gelfond	03/12/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider transactions did IMAX (IMAX) CEO Richard Gelfond report?

Richard Gelfond reported converting stock options into 121,220 IMAX common shares at $31.40 per share, then selling 121,220 common shares at an average price of $40.0993. These moves reflect an exercise-and-sell pattern tied to expiring options.

Was the IMAX (IMAX) CEO’s recent share sale made under a 10b5-1 plan?

Yes, the filing states the option conversion into IMAX common shares occurred under a Rule 10b5-1 trading plan dated December 9, 2026. Such pre-arranged plans automate trading, making the timing more routine and less discretionary.

How many IMAX (IMAX) shares did the CEO sell and at what price?

Richard Gelfond sold 121,220 IMAX common shares in an open-market transaction at an average price of $40.0993 per share. These sales followed the same-day conversion of stock options into an equal number of common shares at $31.40.

What are Richard Gelfond’s remaining IMAX (IMAX) equity holdings after these transactions?

Following the reported transactions, Richard Gelfond directly holds 765,002 IMAX common shares, plus outstanding options over 1,697,475 shares and 231,562 restricted share units. This indicates he still maintains a large ongoing equity position in IMAX.

Were the exercised IMAX (IMAX) stock options close to expiration?

Yes. Footnotes explain these IMAX stock options were issued in 2016 and are set to expire on June 7, 2026. Exercising them now converts time-limited options into common shares before the approaching expiration date.

How many IMAX (IMAX) options did the CEO convert in this Form 4 filing?

The filing shows Richard Gelfond converted 121,220 IMAX stock options into an equal number of common shares at an exercise price of $31.40 per share. This option exercise precedes the reported sale of the same number of common shares.